Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Karmanos Cancer Institute Stories

2010-06-03 08:56:00

Student-Led Venture Fund Participates in $8 Million Series A Round of Financing led by Co-Investor Arboretum Ventures ANN ARBOR, Mich., June 3 /PRNewswire/ -- The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc. Detroit-based Delphinus Medical...

2010-06-02 13:13:00

DETROIT, June 2 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan and the U.S. Centers for Disease Control's Agency for Toxic Substances and Disease Registry (ATSDR), is introducing the Environmental Cancer Program to physicians statewide July 1. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) The program trains primary care physicians to accurately identify and diagnose cancers and other...

2010-05-05 14:50:00

DETROIT, May 5 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute recently received a $2.5 million charitable donation from Franklin, Michigan resident Joseph Dresner to construct the Joseph Dresner Family Bone Marrow Transplant and Hematologic Malignancies Center at its main campus in Detroit. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) According to Karmanos President and Chief Executive Officer Gerold Bepler, M.D., Ph.D., Dresner has generously...

2010-04-27 14:35:00

DETROIT, April 27 /PRNewswire-USNewswire/ -- Guests attending the Barbara Ann Karmanos Cancer Institute's 28th Annual Dinner Gala on Saturday, May 8, at the Rock Financial Showplace, will be dazzled by a stunning fashion show designed by creative icon Linda Dresner. The native Detroiter, world-renowned fashion maven and breast cancer survivor has planned an exciting fashion program that will have attendees feel as if they were in New York or Europe. Guest tables will serve as runways as...

2010-04-19 13:00:00

WASHINGTON, April 19 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research's 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) The title of the poster presentation is, "Genistein...

2010-04-13 13:21:00

DETROIT, April 13 /PRNewswire-USNewswire/ -- Credit Union ONE recently presented a check for $17,000 to the Karmanos Cancer Institute - bringing its fundraising total to more than $1.2 million over the past 23 years, with $400,000 raised just through the credit union's Affinity Card program since it was established in 1995. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) "The Barbara Ann Karmanos Cancer Institute appreciates the efforts of corporate partners that...

2010-03-25 13:51:00

DETROIT, March 25 /PRNewswire-USNewswire/ -- Gerold Bepler, M.D., Ph.D., president and chief executive officer of the Barbara Ann Karmanos Cancer Institute, announced today leadership changes that are effective immediately. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) Ann G. Schwartz, Ph.D., MPH, assumes the position of Deputy Center Director and Executive Vice President of Research and Academic Affairs. Dr. Schwartz served as interim President and CEO of Karmanos...

2010-01-29 07:30:00

DETROIT, Jan. 29 /PRNewswire-USNewswire/ -- After a 10-month nationwide search, Gerold Bepler, M.D., Ph.D., has been named the new president and chief executive officer of the Barbara Ann Karmanos Cancer Institute. A thoracic oncologist, Dr. Bepler will begin his new position Feb. 1, 2010. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) In addition to his chief administrative duties, Dr. Bepler will also serve as principal investigator of Karmanos' National Cancer...

2009-11-16 14:00:00

DETROIT, Nov. 16 /PRNewswire-USNewswire/ -- After more than 10 years of research and development, the Barbara Ann Karmanos Cancer Institute announced its launch of a new company to build and market a breast cancer screening device invented at Karmanos. The innovative technology developed as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as SoftVue, will be marketed under the new spin-off company called Delphinus Medical Technologies, LLC. The company has already...

2009-11-09 12:03:00

DETROIT, Nov. 9 /PRNewswire-USNewswire/ -- For the third consecutive year, the Barbara Ann Karmanos Cancer Center has been selected the most preferred hospital for cancer care in southeast Michigan, according to a survey by the National Research Corporation. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) The annual survey was conducted through an email questionnaire between September 2008 and August 2009. Survey respondents were the primary healthcare decision-makers...